Kindeva Drug Delivery

Paul, Minnesota, and is a contract development and manufacturing organisation for complex drug-device products. Its history includes the 1959 emergency auto-injector, the ComboPen and the BinaJect dual-chamber auto-injector.

Its Meridian division supplies DuoDote, a dual-chamber atropine and pralidoxime auto-injector for nerve agent poisoning, including contracts for the US Strategic National Stockpile; a Kindeva release describes an award of up to 129 million dollars to supply DuoDote auto-injectors. The business is mainly pharmaceutical manufacturing.

Owned by Altaris since 2020, which bought 3M's drug delivery business for 650 million dollars; 3M retained a 17 per cent interest

Parent: Altaris (acquired from 3M) (checked)

• https://www.prnewswire.com/news-releases/kindeva-drug-delivery-formerly-3m-drug-delivery-systems-launches-as-an-independent-company-301051193.html
• https://www.businesswire.com/news/home/20200501005503/en/3M-Completes-Sale-of-Substantially-All-of-Its-Drug-Delivery-Business
• https://www.kindevadd.com/about-us/history/
• https://www.kindevadd.com/resources/how-the-autoinjector-changed-the-world/
• https://www.kindevadd.com/news/kindeva-drug-delivery-awarded-up-to-129-million-to-supply-duodote-autoinjectors-to-the-strategic-national-stockpile/

• Date of the up-to 129 million dollar award: not read.
• Current ownership percentages: not read after 2020.